Genomic Health I Shares Down 30.3% Since SmarTrend's Sell Call (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on March 6th, 2019 at $75.16. In approximately 3 months, Genomic Health I has returned 30.30% as of today's recent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.